The Effects of Almond Consumption on Cardiovascular Health and Gut Microbiome: A Comprehensive Review
Open Access
Abstract
The consumption of almonds has been associated with several health benefits, particularly concerning cardiovascular and intestinal health. In this comprehensive review, we compile and deliberate studies investigating the effects of almond consumption on cardiovascular disease (CVD) risk factors and gut health. Almonds are rich in monounsaturated fats, fiber, vitamins, minerals, and polyphenols, which contribute to their health-promoting properties. Regular intake of almonds has been shown to improve lipid profiles by reducing LDL cholesterol and enhancing HDL functionality. Additionally, almonds aid in glycemic control, blood pressure reduction, and chronic inflammation amelioration, which are critical for cardiovascular health. The antioxidant properties of almonds, primarily due to their high vitamin E content, help in reducing oxidative stress markers. Furthermore, almonds positively influence body composition by reducing body fat percentage and central adiposity and enhancing satiety, thus aiding in weight management. Herein, we also contemplate the emerging concept of the gut–heart axis, where almond consumption appears to modulate the gut microbiome, promoting the growth of beneficial bacteria and increasing short-chain fatty acid production, particularly butyrate. These effects collectively contribute to the anti-inflammatory and cardioprotective benefits of almonds. By encompassing these diverse aspects, we eventually provide a systematic and updated perspective on the multifaceted benefits of almond consumption for cardiovascular health and gut microbiome, corroborating their broader consideration in dietary guidelines and public health recommendations for CVD risk reduction.Keywords
Funding Information
- Almond Board of California
- Florida State University
This publication has 96 references indexed in Scilit:
- The effects of long-term almond consumption on whole-body insulin sensitivity, postprandial glucose responses, and 48 h continuous glucose concentrations in males and females with prediabetes: a randomized controlled trialEuropean Journal of Nutrition, 2023
- Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020JAMA, 2023
- The effect of almond intake on cardiometabolic risk factors, inflammatory markers, and liver enzymes: A systematic review and meta‐analysisPhytotherapy Research, 2022
- Acute feeding with almonds compared to a carbohydrate-based snack improves appetite-regulating hormones with no effect on self-reported appetite sensations: a randomised controlled trialEuropean Journal of Nutrition, 2022
- Effects of almond on cardiometabolic outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trialsPhytotherapy Research, 2022
- Effects of almonds on ameliorating salt‐induced hypertension in dahl salt‐sensitive ratsJournal of the Science of Food and Agriculture, 2021
- Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018JAMA, 2021
- Whole almond consumption is associated with better diet quality and cardiovascular disease risk factors in the UK adult population: National Diet and Nutrition Survey (NDNS) 2008–2017European Journal of Nutrition, 2020
- In vitro and in vivo evaluation of the prebiotic effect of raw and roasted almonds (Prunus amygdalus)Journal of the Science of Food and Agriculture, 2016
- A mid-morning snack of almonds generates satiety and appropriate adjustment of subsequent food intake in healthy womenEuropean Journal of Nutrition, 2014